Find insight on Novo Nordisk and more in the latest Market Talks covering the Health Care sector..

Jo Walton. Tor, $25.99 (368p) ISBN 978-0-7653-3266-0. Hugo-winner Walton (My Real Children) explores the temptations and pitfalls of utopia in a genre-bending thought experiment: what if the Greek ...

Its net profit in the first quarter rose 14% to 29.03 billion kroner, ahead of 28.08 billion kroner forecast by analysts in a FactSet poll. Sales rose 19% to 78.09 billion kroner, beating analysts ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Jo Walton is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current ...